Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Qiyu, Tang"'
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/a8aed31777e44eb0aeb7a01202f52cf0
Autor:
Qiyu Tang, Guo Zhao, Hong Fang, Yale Jiang, Peiwen Ma, Jiawei Zhou, Dongyan Liu, Shujun Xing, Gaoquan Li, Nian Liu, Huiyu Chen, Shuhang Wang, Ning Li
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 6, Pp 2786-2789 (2024)
Externí odkaz:
https://doaj.org/article/b3c3d10d513f444d9bd1842c7db5f468
Autor:
Peiyun Wang, Ying Zhang, Zhixing Li, Shenglan Zhou, Qiyu Tang, Zujia Wang, Rou Xiao, Mai Feng, Lingqian Wu, Desheng Liang
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 19, p 10394 (2024)
Human-induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (iMSCs) represent a promising and renewable cell source for therapeutic applications. A systematic evaluation of the immunological properties and engraftment potential of iMSCs
Externí odkaz:
https://doaj.org/article/a603fc5f78ee4a0e8e1d65d4f602d8ac
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/c2cc8c511c2d45d5aa8cd13f0e515086
Autor:
Rou Xiao, Yan Chen, Zhiqing Hu, Qiyu Tang, Peiyun Wang, Miaojin Zhou, Lingqian Wu, Desheng Liang
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 7, p 3635 (2024)
Hemophilia A (HA) is a common X-linked recessive hereditary bleeding disorder. Coagulation factor VIII (FVIII) is insufficient in patients with HA due to the mutations in the F8 gene. The restoration of plasma levels of FVIII via both recombinant B-d
Externí odkaz:
https://doaj.org/article/87789689c9b74fe69c5ffde30c9e5eeb
Publikováno v:
Frontiers in Veterinary Science, Vol 10 (2023)
BackgroundTGFβ signaling appears to contribute to the pathogenesis of myxomatous mitral valve disease (MMVD) in both dogs and humans. However, little is known about the extent of the downstream signaling changes that will then affect cell phenotype
Externí odkaz:
https://doaj.org/article/2f3478e8fd424d18a0516a1ff155b0bd
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Anti-PD-(L)1 antibody monotherapy or in combination with VEGF(R) blockade has been applied widely for cancer treatment. Whether combination therapy increases irAEs still remains controversial.Methods: A systematic review and meta-analysis
Externí odkaz:
https://doaj.org/article/2b7085db906f4633a912a765ab032bc2
Autor:
Shuhang Wang, Yuqi Yang, Peiwen Ma, Huiyao Huang, Qiyu Tang, Huilei Miao, Yuan Fang, Ning Jiang, Yandong Li, Qi Zhu, Wei Tao, Yan Zha, Ning Li
Publikováno v:
Molecular Therapy: Oncolytics, Vol 24, Iss , Pp 799-813 (2022)
Tumor-associated macrophages (TAMs) exert integrated effects in all aspects of tumor progression, including tumor cell proliferation, angiogenesis, invasion, and metastasis. Recently, considerable preclinical and clinical trials have demonstrated tha
Externí odkaz:
https://doaj.org/article/5916967ceeb548f4917300a56f89afbe
Autor:
Huiyao Huang, Yu Tang, Yue Yu, Anqi Yu, Dawei Wu, Hong Fang, Shuhang Wang, Chao Sun, Xin Wang, Qi Fan, Yuan Fang, Qiyu Tang, Ning Jiang, Jingting Du, Huilei Miao, Ying Bai, Peiwen Ma, Shujun Xing, Dandan Cui, Shuangman Miao, Yale Jiang, Jingxiao Zhu, Qi Zhu, Ye Leng, Lan Wei Guo, Shanmei Liao, Yaguang Shao, Yinyin Song, Zeyuan Liu, Minghuang Hong, Suxia Luo, Binghe Xu, Gongtao Lan, Ning Li
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 31, Iss , Pp 100624- (2023)
Summary: Overall survival (OS) is considered the standard clinical endpoint to support effectiveness claims in new drug applications globally, particularly for lethal conditions such as cancer. However, the source and reliability of OS in the setting
Externí odkaz:
https://doaj.org/article/3ab02991cce14189a287c6d0d11b5e87
Autor:
Shuhang Wang, Yale Jiang, Huilei Miao, Yuan Fang, Ning Jiang, Yue Yu, Peiwen Ma, Qiyu Tang, Dandan Cui, Hong Fang, Huiyao Huang, Qi Fan, Chao Sun, Anqi Yu, Shuangman Miao, Jingting Du, Jingxiao Zhu, Yuning Wang, Ning Li
Publikováno v:
EMBO Molecular Medicine, Vol 15, Iss 1, Pp n/a-n/a (2023)
Rare tumor has a huge unmet medical need without standard regimens, calling for novel therapeutic interventions. The National Cancer Center of China identified a threshold of incidence for rare tumor as 2.5/100,000, based on the characteristics of Ch
Externí odkaz:
https://doaj.org/article/1aec64bcd68642c58834e7e40261dcc9